IL4I1: a novel molecular biomarker represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer.
- DOI
- 10.3389/fphar.2024.1365683
- Published
- 2024
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2024.1365683,
title = {IL4I1: a novel molecular biomarker represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer.},
author = {Peng X and Liu C and Zhang L and Chen Y and Mao L and Gao S and Shi X and Zuo L},
year = {2024},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2024.1365683},
url = {https://doi.org/10.3389/fphar.2024.1365683}
}RIS
TY - JOUR TI - IL4I1: a novel molecular biomarker represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer. AU - Peng X AU - Liu C AU - Zhang L AU - Chen Y AU - Mao L AU - Gao S AU - Shi X AU - Zuo L PY - 2024 JO - Frontiers in pharmacology DO - 10.3389/fphar.2024.1365683 UR - https://doi.org/10.3389/fphar.2024.1365683 ER -
APA
X, P., C, L., L, Z., Y, C., L, M., S, G., X, S., & L, Z. (2024). IL4I1: a novel molecular biomarker represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2024.1365683
Source records
- pubmed · retrieved 2026-09-26T17:03:46.317Z